| 0QBO Stock | | | 886.80 11.35 1.30% |
At this time, the firm appears to be
overvalued.
Coloplast AS shows a prevailing
Real Value of USD647.36 per share. The current price of the firm is USD886.8. Our model approximates the value of
Coloplast AS from analyzing the firm
fundamentals such as Return On Equity of 0.29,
profit margin of
0.19 %, and Current Valuation of 222.57
B as well as examining its
technical indicators and
probability of bankruptcy.
Overvalued
Please note that Coloplast's price fluctuation is
very steady at this time. Calculation of the real value of Coloplast AS is based on 3 months time horizon. Increasing Coloplast's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Coloplast stock is determined by what a typical buyer is willing to pay for full or partial control of Coloplast AS. Since Coloplast is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Coloplast Stock. However, Coloplast's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
| Historical | Market 886.8 | Real 647.36 | Hype 886.86 | Naive 879.77 |
The intrinsic value of Coloplast's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence
Coloplast's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Coloplast AS helps investors to forecast how Coloplast stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Coloplast more accurately as focusing exclusively on Coloplast's fundamentals will not take into account other important factors:
Coloplast Total Value Analysis
Coloplast AS is presently projected to have takeover price of 222.57
B with market capitalization of 190.16
B, debt of , and cash on hands of . Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the
Coloplast fundamentals before making investing decisions based on enterprise value of the company
Coloplast Investor Information
About
35.0% of the company shares are owned by insiders or employees . The company had not issued any dividends in recent years. Coloplast AS had
5:1 split on the 19th of December 2012. Based on the key indicators related to Coloplast's liquidity, profitability, solvency, and operating efficiency, Coloplast AS is not in a good financial situation at this time. It has a very high probability of going through financial hardship in December.
Coloplast Asset Utilization
One of the ways to look at asset utilization of Coloplast is to check how much profit was generated for every dollar of assets it reports. Coloplast AS utilizes its assets nearly 0.0949 percent, earning 0.0949 cents for each dollar of assets held by the firm. An expanding asset utilization signifies that the company is being more effective with each dollar of assets it shows. Put another way, asset utilization of Coloplast shows how effective it operates for each dollar spent on its assets.
Coloplast Ownership Allocation
The
market capitalization of Coloplast AS is USD190.16 Billion. Coloplast AS retains significant amount of outstanding shares owned by
insiders. An
insider is usually defined as a CEO, other corporate executive, director, or
institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please take into account that even companies with profitable outlook can generate negative future returns on their equity. If the true value of the firm is less than the current market value, you may not be able generate positive returns on investment in the long run.
Coloplast Profitability Analysis
The company reported the revenue of 27.03
B.
Net Income was 4.78
B with profit before overhead, payroll, taxes, and interest of 15.53
B.
The stock valuation mechanism determines Coloplast's current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of Coloplast AS based exclusively on its
indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of Coloplast. We calculate exposure to Coloplast's
them to those of Coloplast's related companies.
When running Coloplast's price analysis, check to
measure Coloplast's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Coloplast is operating at the current time. Most of Coloplast's value examination focuses on studying past and present price action to
predict the probability of Coloplast's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Coloplast's price. Additionally, you may evaluate how the addition of Coloplast to your portfolios can decrease your overall portfolio volatility.